Javier Montoya

Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

Vicente Villanueva, Mercedes Garcés, Francisco Javier López‐González et al. · Epilepsy Research · 2016 · 130 citations

Pharmacy, Pharmacology, Pharmacotherapy +5

Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12‐month GENERAL study

Vicente Villanueva, Javier Montoya, Ascensión Castillo et al. · Epilepsia · 2018 · 113 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

Vicente Villanueva, Francisco Javier López‐González, J.A. Mauri et al. · Acta Neurologica Scandinavica · 2018 · 84 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +7

Treatment monitoring of 0.5% 5‐fluorouracil and 10% salicylic acid in clinical and subclinical actinic keratoses with the combination of optical coherence tomography and reflectance confocal microscopy

Josep Malvehy, Ivette Alarcón, Javier Montoya et al. · Journal of the European Academy of Dermatology and Venereology · 2015 · 33 citations · Full text

Medicine, Dermatology, Ophthalmology +13

Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

Francisco Gil-López, Javier Montoya, Mercè Falip et al. · Acta Neurologica Scandinavica · 2018 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +17